GBGB9703103.3A
GB9703103D0
(en)
|
1997-02-14 |
1997-02-14 |
Protein
|
GBGB9707599.8A
GB9707599D0
(en)
|
1996-05-04 |
1997-04-15 |
Proteins
|
NZ331978A
NZ331978A
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to CEA (carcinomembryonic antigen), conjugates comprising said antibody, and their therapeutic use in an adept system
|
HU9901562A
HUP9901562A3
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
|
DE69737188T
DE69737188T2
(en)
|
1996-05-04 |
1997-04-29 |
MONOCLONAL ANTIBODY AGAINST CEA, CONJUGATES CONTAINING THIS ANTIBODY AND THEIR THERAPEUTIC USE IN AN ADEPT SYSTEM
|
PCT/GB1997/001165
WO1997042329A1
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
|
PL97329871A
PL329871A1
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody agains cea, coniugates incorporating that antibody and their therapeutic application in the adept system
|
CA002250579A
CA2250579A1
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
|
EP97918258A
EP0896626B1
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
|
TR1998/02227T
TR199802227T2
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody against CEA, conjugates containing said antibody and their therapeutic use in an ADEPT system.
|
CZ983536A
CZ353698A3
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody against cea, conjugates in which it is comprised, process of their preparation and pharmaceutical composition containing thereof
|
AU26455/97A
AU719513B2
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
|
JP09539625A
JP2000510692A
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibodies to CEA, conjugates comprising the antibodies, and their therapeutic use in ADEPT systems
|
ES97918258T
ES2279539T3
(en)
|
1996-05-04 |
1997-04-29 |
ANTI-CEA MONOCLONAL ANTIBODY, CONJUGATES UNDERSTANDING ANTIBODY, AND THERAPEUTIC USE IN AN ADEPT SYSTEM.
|
US09/171,945
US6277599B1
(en)
|
1996-05-04 |
1997-04-29 |
Anti-CEA antibody designated 806.077, hybridoma and method of manufacture
|
IL12677297A
IL126772A0
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody of cea conjugates comprising said antibody and their therapeutic use in an adept system
|
CN97194390A
CN1217750A
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
|
AT97918258T
ATE350478T1
(en)
|
1996-05-04 |
1997-04-29 |
MONOCLONAL ANTIBODIES TO CEA, CONJUGATES CONTAINING THIS ANTIBODIES AND THEIR THERAPEUTIC USE IN AN ADEPT SYSTEM
|
SK1502-98A
SK150298A3
(en)
|
1996-05-04 |
1997-04-29 |
Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
|
BR9708910A
BR9708910A
(en)
|
1996-05-04 |
1997-04-29 |
Conjugated antibody polynucleotide sequence vector host cell hybridoma pharmaceutical composition processes for making an antibody or conjugate and for treating a human or animal in need of this treatment
|
NO985120A
NO985120L
(en)
|
1996-05-04 |
1998-11-03 |
Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic deployment in an ADEPT system
|
US09/910,059
US6903203B2
(en)
|
1996-05-04 |
2001-07-23 |
Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic use
|